Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP681452.RAdLYFQPeFgfytR2k0ggwsGirZu9ZLMKJ9mPqLB2nsSJY130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681452.RAdLYFQPeFgfytR2k0ggwsGirZu9ZLMKJ9mPqLB2nsSJY130_provenance.
• NP711865.RAe1cTJ4l9eWiWm38ayAyLuPgP9Ww_nbg7lgn3XwgGyiU130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711865.RAe1cTJ4l9eWiWm38ayAyLuPgP9Ww_nbg7lgn3XwgGyiU130_provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP685715.RAaWpYyghJE_Zp7LQxLLdiL1mwov7EZMaIIGjc7yblUzM130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685715.RAaWpYyghJE_Zp7LQxLLdiL1mwov7EZMaIIGjc7yblUzM130_provenance.
• NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685721.RAf6PseK_gI-PPf3DEw36Al8VuB1pza1uh7Ulw3t9CD3I130_provenance.
• NP685722.RAVOtH0gY4tu97HXUFEWKI0XoqpJyvrtZU4HcNYtbZiVA130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685722.RAVOtH0gY4tu97HXUFEWKI0XoqpJyvrtZU4HcNYtbZiVA130_provenance.
• NP685723.RAVi5gWsXy48bXG1H2U-8uCYtVBHgbDTDjxF-XCflf4TA130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685723.RAVi5gWsXy48bXG1H2U-8uCYtVBHgbDTDjxF-XCflf4TA130_provenance.
• NP685726.RATmc1wF6f4vFbaeRjCdVmF-kadJuiMt1n3rSJL3kGxuc130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685726.RATmc1wF6f4vFbaeRjCdVmF-kadJuiMt1n3rSJL3kGxuc130_provenance.
• NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685727.RAaaVzJtjEku1iYpHTkj8i6hoRks8mAfJXfXJ1lBHqlb4130_provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP711863.RAqNZ9NCf0ZF0NiZBBqDuzBYYcB1aJC4-mRqJQzCGStTA130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP711863.RAqNZ9NCf0ZF0NiZBBqDuzBYYcB1aJC4-mRqJQzCGStTA130_provenance.
• NP685720.RAlpApa2qHatJFRg3ADClfK5pFAAkq2zXQIvofJI81ixE130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685720.RAlpApa2qHatJFRg3ADClfK5pFAAkq2zXQIvofJI81ixE130_provenance.
• NP960144.RAN0yBoLhsSEiAcmtvNg-2CK15e94pddQuF1uAWIqNq4Q130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960144.RAN0yBoLhsSEiAcmtvNg-2CK15e94pddQuF1uAWIqNq4Q130_provenance.
• NP685724.RAM7oNtrAF05WifyBews7bN2KKRVvHpEGw9p2V9q6baEo130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685724.RAM7oNtrAF05WifyBews7bN2KKRVvHpEGw9p2V9q6baEo130_provenance.
• NP681451.RAOdYinrK7XeGD51rYia53SNHf_iIe76ZJkKDsi6jN2Pw130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP681451.RAOdYinrK7XeGD51rYia53SNHf_iIe76ZJkKDsi6jN2Pw130_provenance.
• NP685718.RAyeGjCeYt661ox7BfB-_1wcgrVD45RM83IPRKnD34GTY130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685718.RAyeGjCeYt661ox7BfB-_1wcgrVD45RM83IPRKnD34GTY130_provenance.
• NP685719.RA4JHrNjf0hX-of0boeZShZ-FxTZkZA71_6slSYdg0J8c130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP685719.RA4JHrNjf0hX-of0boeZShZ-FxTZkZA71_6slSYdg0J8c130_provenance.
• NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_assertion description "[In microdissected prostate tumor cells from 122 patients, relative abundance of these variants was in the following order: ERG8 > TEPC > ERG 3 > ERG1/2 with combined overexpression rate of 62.3% in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP960145.RA8gfUIM5-gH8N3lGTYByIRlY05z8y4gE8z_FBFYv6Ps4130_provenance.